Are you Dr. Velasquez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 64 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7737 Southwest Fwy
Suite 575
Houston, TX 77074Phone+1 713-778-0300Fax+1 713-778-0303
Summary
- Dr. William Velasquez, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Kentucky. He is affiliated with Memorial Hermann Southwest Hospital, Memorial Hermann Memorial City Medical Center, and St. Luke's Health - Baylor St. Luke's Medical Center.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1975 - 1976
- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1973 - 1975
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1975
- UMass Chan Medical SchoolResidency, Internal Medicine, 1971 - 1973
- National University of San MarcosClass of 1968
Certifications & Licensure
- TX State Medical License 1977 - 2026
- KY State Medical License 1990 - 2005
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1995
Publications & Presentations
PubMed
- 45 citationsClinical features and results of management of superior vena cava syndrome secondary to lymphoma.Roman Perez-Soler, Patricia J. McLaughlin, W. S. Velasquez, Fredrick B. Hagemeister, J Zornoza
Journal of Clinical Oncology. 1984-04-01 - 86 citationsStage I-II follicular lymphoma. Treatment results for 76 patients.P. McLaughlin, Lillian M. Fuller, William S. Velasquez, Jane A. Sullivan-Halley, James J. Butler
Cancer. 1986-10-15 - 51 citationsEtoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.Bart Barlogie, W. S. Velasquez, Raymond Alexanian, Fernando Cabanillas
Journal of Clinical Oncology. 1989-10-01
Professional Memberships
- Fellow